Phio Pharmaceuticals Corp. (PHIO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Phio Pharmaceuticals Corp...

    NASDAQ: PHIO · Real-Time Price · USD
    2.32
    -0.15 (-6.07%)
    At close: Sep 11, 2025, 3:59 PM
    2.29
    -1.29%
    After-hours: Sep 11, 2025, 07:45 PM EDT

    Phio Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 5.38M 8.49M 11.78M 24.06M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a 3K 24K 27K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 354K 832K 665K 50K
    Total Current Assets
    		 5.74M 9.32M 12.45M 24.73M
    Property-Plant & Equipment
    		 2K 39K 344K 416K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 2K 42K 368K 443K
    Total Assets
    		 5.74M 9.36M 12.81M 25.17M
    Account Payables
    		 253K 657K 779K 283K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 135K 125K
    Other Current Liabilities
    		 731K 720K 482K 1.96M
    Total Current Liabilities
    		 1.01M 1.63M 1.8M 3.07M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a 2K n/a
    Total Long-Term Liabilities
    		 n/a n/a 172K 170K
    Total Liabilities
    		 1.01M 1.63M 1.98M 3.24M
    Total Debt
    		 n/a 35K 305K 295K
    Common Stock
    		 n/a n/a n/a 1K
    Retained Earnings
    		 -146.36M -139.21M -128.38M -116.9M
    Comprehensive Income
    		 n/a -0.00 n/a 0.00
    Shareholders Equity
    		 4.72M 7.73M 10.84M 21.93M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist